Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Depreciation and Depletion (2022 - 2023)

Historic Depreciation and Depletion for Candel Therapeutics (CADL) over the last 2 years, with Q4 2023 value amounting to $289000.0.

  • Candel Therapeutics' Depreciation and Depletion rose 1893.0% to $289000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $919000.0, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Candel Therapeutics reported Depreciation and Depletion of $289000.0 as of Q4 2023, which was up 1893.0% from $200000.0 recorded in Q3 2023.
  • Over the past 5 years, Candel Therapeutics' Depreciation and Depletion peaked at $289000.0 during Q4 2023, and registered a low of $200000.0 during Q2 2023.